ERIN SATTAZAHN: Open Payments
NPI 1437409315 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 66 payments from 13 companies in 2025. Trend: 2023 $1,185 · 2024 $1,173 · 2025 $1,210
Food & beverage: $1,196Education: $14
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $310 |
| ABBVIE INC. | 17 | $263 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $184 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $92 |
| Ardelyx, Inc. | 4 | $73 |
| PFIZER INC. | 4 | $65 |
| Gilead Sciences, Inc. | 3 | $47 |
| Ferring Pharmaceuticals Inc. | 2 | $44 |
| Janssen Scientific Affairs, LLC | 1 | $37 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
Products named: TREMFYA, RINVOQ, ENTYVIO, XIFAXAN, EOHILIA, IBSRELA, MAVYRET, XELJANZ.
Industry payments across MI — which companies pay providers there.
